Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 8, 2015-08 ,pp. : 726-733

John Wiley & Sons Inc

Access to resources Recommend Favorite

Parenteral nutrition in critical care

By Macdonald Kirsten   Page Kevin   Brown Lisa   Bryden Daniele  

Continuing Education in Anaesthesia, Critical Care & Pain, Vol. 13, Iss. 1, 2013-02 ,pp. : 1-5

Oxford University Press

Access to resources Recommend Favorite

Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin‐naïve or previously treated with insulin glargine: a randomized, double‐blind controlled trial (the ELEMENT 2 study)

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 8, 2015-08 ,pp. : 734-741

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fish Oil-Supplemented Parenteral Nutrition in Severe Acute Pancreatitis Patients and Effects on Immune Function and Infectious Risk: A Randomized Controlled Trial

By Wang Xinying   Li Weiqin   Zhang Feng   Pan Liya   Li Ning   Li Jieshou  

Inflammation, Vol. 32, Iss. 5, 2009-10 ,pp. : 304-309

Springer Publishing Company

Access to resources Recommend Favorite

Subcutaneous versus intravenous insulin therapy for glucose control in non‐diabetic trauma patients. A randomized controlled trial

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 38, Iss. 1, 2013-02 ,pp. : 24-30

John Wiley & Sons Inc

Access to resources Recommend Favorite